Entropy Neurodynamics Ltd (ENP)

Currency in AUD
0.034
-0.001(-2.86%)
Closed·
Earnings results expected in 7 days
ENP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0340.035
52 wk Range
0.0270.046
Key Statistics
Bid/Ask
0.034 / 0.031
Prev. Close
0.035
Open
0.035
Day's Range
0.034-0.035
52 wk Range
0.027-0.046
Volume
2.58M
Average Volume (3m)
2.3M
1-Year Change
-8.1081%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Neutral
Moving Averages
Strong Buy

Entropy Neurodynamics Company Profile

Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States. The company’s lead program candidate is TRP-8803, a formulation of IV-infused psilocin that completed Phase 2 clinical trial for the treatment of binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. It is also involved in the development of TRP-8802, a synthetic and oral psilocybin currently under phase 2a clinical trial for the treatment of binge eating, as well as under phase 2 clinical stage for the treatment of fibromyalgia and irritable bowel syndrome. The company was formerly known as Tryptamine Therapeutics Limited and changed its name to Entropy Neurodynamics Limited in November 2025. Entropy Neurodynamics Limited was founded in 2019 and is based in Camberwell, Australia.

Compare ENP to Peers and Sector

Metrics to compare
ENP
Peers
Sector
Relationship
P/E Ratio
−10.6x−11.6x−0.6x
PEG Ratio
−0.14−0.060.00
Price/Book
9.5x5.6x2.6x
Price / LTM Sales
35.7x30.7x3.4x
Upside (Analyst Target)
-111.1%42.0%
Fair Value Upside
Unlock−3.7%5.8%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Entropy Neurodynamics (ENP) Share Price Today?

The live Entropy Neurodynamics share price today is 0.034

What Stock Exchange Does Entropy Neurodynamics (ENP) Trade On?

Entropy Neurodynamics is listed and trades on the Sydney Stock Exchange.

What Is the Ticker (Stock Symbol) for Entropy Neurodynamics?

The stock symbol (also called a 'ticker') for Entropy Neurodynamics is "ENP."

What Is the Current Entropy Neurodynamics Market Cap?

As of today, Entropy Neurodynamics market capitalisation is 54.79M.

What Is Entropy Neurodynamics's (ENP) Earnings Per Share (TTM)?

The Entropy Neurodynamics EPS is currently -0.00 (Trailing Twelve Months).

When Is the Next Entropy Neurodynamics Earnings Date?

Entropy Neurodynamics's next earnings report will be released on 28 Jan 2026.

Is ENP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Entropy Neurodynamics moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Entropy Neurodynamics Stock Split?

Entropy Neurodynamics has split 1 times. (See the ENP stock split history page for full effective split date and price information.)

What is the current trading status of Entropy Neurodynamics (ENP)?

As of 21 Jan 2026, Entropy Neurodynamics (ENP) is trading at a price of 0.034, with a previous close of 0.035. The stock has fluctuated within a day range of 0.034 to 0.035, while its 52-week range spans from 0.027 to 0.046.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.